SC 13G/A

0001193125-15-035118.txt : 20150205 0001193125-15-035118.hdr.sgml : 20150205 20150205134801 ACCESSION NUMBER: 0001193125-15-035118 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 GROUP MEMBERS: ANSBERT GADICKE GROUP MEMBERS: JAMES PAUL SCOPA GROUP MEMBERS: LUKE EVNIN GROUP MEMBERS: MPM ASSET MANAGEMENT INVESTORS BV4 LLC GROUP MEMBERS: MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG GROUP MEMBERS: MPM BIOVENTURES IV GP LLC GROUP MEMBERS: MPM BIOVENTURES IV LLC GROUP MEMBERS: MPM BIOVENTURES IV STRATEGIC FUND, L.P. GROUP MEMBERS: TODD FOLEY GROUP MEMBERS: VAUGHN M. KAILIAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Epizyme, Inc. CENTRAL INDEX KEY: 0001571498 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261349956 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87481 FILM NUMBER: 15579377 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-229-5872 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MPM BioVentures IV QP LP CENTRAL INDEX KEY: 0001358309 IRS NUMBER: 204217788 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 SC 13G/A 1 d868247dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)*

EpiZyme, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

29428V104

(CUSIP Number)

December 31, 2014

(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 29428V104


1.	Name of Reporting Persons MPM BioVentures IV-QP, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 1,951,645
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 1,951,645
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,951,645
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 5.7%
12.	Type of Reporting Person (See Instructions) PN

Page 2 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons MPM BioVentures IV GmbH & Co. Beteiligungs KG
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Germany
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 75,188
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 75,188
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 75,188
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 0.2%
12.	Type of Reporting Person (See Instructions) PN

Page 3 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons MPM BioVentures IV Strategic Fund, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 331,491
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 331,491
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 331,491
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.0%
12.	Type of Reporting Person (See Instructions) PN

Page 4 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons MPM Asset Management Investors BV4 LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 55,495
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 55,495
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 55,495
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 0.2%
12.	Type of Reporting Person (See Instructions) OO

Page 5 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons MPM BioVentures IV GP LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,358,324*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,358,324*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,358,324*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 6.9%
12.	Type of Reporting Person (See Instructions) PN

*	The shares are held as follows: 1,951,645 by MPM BioVentures IV-QP, L.P. (“BV IV QP”), 75,188 by MPM BioVentures IV GmbH & Co. Beteiligungs KG (“BV KG”) and 331,491 by MPM BioVentures IV Strategic Fund, L.P. (“BV SF”). The Reporting Person is the direct general partner of BV IV QP, BV KG and BV SF.

Page 6 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons MPM BioVentures IV LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,413,819*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,413,819*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,413,819*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 7.1%
12.	Type of Reporting Person (See Instructions) OO

*	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by MPM Asset Management Investors BV4 LLC (“AM BV4”). The Reporting Person is the indirect general partner of BV IV QP, BV KG and BV SF and the manager of AM BV4.

Page 7 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons Luke Evnin
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,413,819*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,413,819*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,413,819*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 7.1%
12.	Type of Reporting Person (See Instructions) IN

The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM BioVentures IV GP LLC (“MPM IV GP”) and MPM BioVentures IV LLC (“MPM IV LLC”) are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC.

Page 8 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons Ansbert Gadicke
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,413,819*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,413,819*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,413,819*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 7.1%
12.	Type of Reporting Person (See Instructions) IN

*	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC.

Page 9 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons Vaughn M. Kailian
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,413,819*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,413,819*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,413,819*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 7.1%
12.	Type of Reporting Person (See Instructions) IN

*	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC.

Page 10 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons James Paul Scopa
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,413,819*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,413,819*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,413,819*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 7.1%
12.	Type of Reporting Person (See Instructions) IN

*	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC.

Page 11 of 18

CUSIP No. 29428V104


1.	Name of Reporting Persons Todd Foley
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 2,413,819*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 2,413,819*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,413,819*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 7.1%
12.	Type of Reporting Person (See Instructions) IN

*	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC.

Page 12 of 18

Item 1.

(a)

Name of Issuer

EpiZyme, Inc.

(b)

Address of Issuer’s Principal Executive Offices

400 Technology Square

Cambridge, Massachusetts 02139

Item 2.

(a)

Name of Person Filing

MPM BioVentures IV-QP, L.P.

MPM BioVentures IV GmbH & Co. Beteiligungs KG

MPM Asset Management Investors BV4 LLC

MPM BioVentures IV GP LLC

MPM BioVentures IV LLC

MPM BioVentures IV Strategic Fund, L.P.

Luke Evnin

Ansbert Gadicke

Vaughn M. Kailian

James Paul Scopa

Todd Foley

(b)

Address of Principal Business Office or, if none, Residence

c/o MPM Capital LLC

The John Hancock Tower

200 Clarendon Street, 54^th Floor

Boston, MA 02116

(c)

Citizenship

All entities were organized in Delaware except MPM BioVentures IV GmbH & Co. Beteiligungs KG, which was organized in Germany. The individuals are all United States citizens.

(d)

Title of Class of Securities

Common Stock

(e)

CUSIP Number

29428V104

Item 3.

If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Page 13 of 18

Item 4.

Ownership

(a)

Amount Beneficially Owned:


MPM BioVentures IV-QP, L.P.	1,951,645
MPM BioVentures IV GmbH & Co. Beteiligungs KG	75,188
MPM BioVentures IV Strategic Fund, L.P.	331,491
MPM Asset Management Investors BV4 LLC	55,495
MPM BioVentures IV GP LLC	2,358,324	(1)
MPM BioVentures IV LLC	2,413,819	(2)
Ansbert Gadicke	2,413,819	(3)
Luke B. Evnin	2,413,819	(3)
Vaughn M. Kailian	2,413,819	(3)
James Paul Scopa	2,413,819	(3)
Todd Foley	2,413,819	(3)

Percent of Class:


MPM BioVentures IV-QP, L.P.			5.7%
MPM BioVentures IV GmbH & Co. Beteiligungs KG			0.2%
MPM BioVentures IV Strategic Fund, L.P.			1.0%
MPM Asset Management Investors BV4 LLC			0.2%
MPM BioVentures IV GP LLC			6.9%
MPM BioVentures IV LLC			7.1%
Ansbert Gadicke			7.1%
Luke B. Evnin			7.1%
Vaughn M. Kailian			7.1%
James Paul Scopa			7.1%
Todd Foley			7.1%

(b)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote


MPM BioVentures IV-QP, L.P.			1,951,645
MPM BioVentures IV GmbH & Co. Beteiligungs KG			75,188
MPM BioVentures IV Strategic Fund, L.P.			331,491
MPM Asset Management Investors BV4 LLC			55,495
MPM BioVentures IV GP LLC			0
MPM BioVentures IV LLC			0
Ansbert Gadicke			0
Luke B. Evnin			0
Vaughn M. Kailian			0
James Paul Scopa			0
Todd Foley			0

Page 14 of 18

(ii)

Shared power to vote or to direct the vote


MPM BioVentures IV-QP, L.P.	0
MPM BioVentures IV GmbH & Co. Beteiligungs KG	0
MPM BioVentures IV Strategic Fund, L.P.	0
MPM Asset Management Investors BV4 LLC	0
MPM BioVentures IV GP LLC	2,358,324	(1)
MPM BioVentures IV LLC	2,413,819	(2)
Ansbert Gadicke	2,413,819	(3)
Luke B. Evnin	2,413,819	(3)
Vaughn M. Kailian	2,413,819	(3)
James Paul Scopa	2,413,819	(3)
Todd Foley	2,413,819	(3)

(iii)

Sole power to dispose or to direct the disposition of


MPM BioVentures IV-QP, L.P.			1,951,645
MPM BioVentures IV GmbH & Co. Beteiligungs KG			75,188
MPM BioVentures IV Strategic Fund, L.P.			331,491
MPM Asset Management Investors BV4 LLC			55,495
MPM BioVentures IV GP LLC			0
MPM BioVentures IV LLC			0
Ansbert Gadicke			0
Luke Evnin			0
Vaughn M. Kailian			0
James Paul Scopa			0
Todd Foley			0

(iv)

Shared power to dispose or to direct the disposition of


MPM BioVentures IV-QP, L.P.	0
MPM BioVentures IV GmbH & Co. Beteiligungs KG	0
MPM BioVentures IV Strategic Fund, L.P.	0
MPM Asset Management Investors BV4 LLC	0
MPM BioVentures IV GP LLC	2,358,324	(1)
MPM BioVentures IV LLC	2,413,819	(2)
Ansbert Gadicke	2,413,819	(3)
Luke B. Evnin	2,413,819	(3)
Vaughn M. Kailian	2,413,819	(3)
James Paul Scopa	2,413,819	(3)
Todd Foley	2,413,819	(3)

(1)	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG and 331,491 by BV SF. The Reporting Person is the direct general partner of BV IV QP, BV KG and BV SF.

(2)	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. The Reporting Person is the indirect general partner of BV IV QP, BV KG and BV SF and the manager of AM BV4.

(3)	The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC.

Page 15 of 18

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group

Not Applicable

Item 9.

Notice of Dissolution of a Group

Not Applicable

Item 10.

Certification

Not Applicable

Page 16 of 18

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 4, 2015


MPM BIOVENTURES IV-QP, L.P.		MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

By:	MPM BioVentures IV GP LLC, its General Partner	By:	MPM BioVentures IV GP LLC, in its capacity as the Managing Limited Partner

By:	MPM BioVentures IV LLC, its Managing Member	By:	MPM BioVentures IV LLC, its Managing Member

By:	/s/ Luke Evnin	By:	/s/ Luke Evnin
	Name: Luke Evnin Title: Member		Name: Luke Evnin Title: Member

MPM ASSET MANAGEMENT INVESTORS BV4 LLC		MPM BIOVENTURES IV STRATEGIC FUND, L.P.

By:	MPM BioVentures IV LLC its Manager	By:	MPM BioVentures IV GP LLC, its General Partner

By:	/s/ Luke Evnin	By:	MPM BioVentures IV LLC,
	Name: Luke Evnin Title: Member		its Managing Member

		By:	/s/ Luke Evnin
		Name: Title:	Luke Evnin Member

MPM BIOVENTURES IV GP LLC		MPM BIOVENTURES IV LLC

By:	MPM BioVentures IV LLC,	By:	/s/ Luke Evnin
	its Managing Member	Name: Title:	Luke Evnin Member

By:	/s/ Luke Evnin
Name: Title:	Luke Evnin Member

By:	/s/ Luke Evnin	By:	/s/ Ansbert Gadicke
	Name: Luke Evnin		Name: Ansbert Gadicke

By:	/s/ Vaughn M. Kailian	By:	/s/ James Paul Scopa
	Name: Vaughn M. Kailian		Name: James Paul Scopa

By:	/s/ Todd Foley
	Name: Todd Foley

EXHIBITS

A:	Joint Filing Agreement

Page 17 of 18

EX-99.A 2 d868247dex99a.htm EX-A EX-A

EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of EpiZyme, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 4^th day of February, 2015.


MPM BIOVENTURES IV-QP, L.P.		MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

By:	MPM BioVentures IV GP LLC, its General Partner	By:	MPM BioVentures IV GP LLC, in its capacity as the Managing Limited Partner

By:	MPM BioVentures IV LLC, its Managing Member	By:	MPM BioVentures IV LLC, its Managing Member

By:	/s/ Luke Evnin	By:	/s/ Luke Evnin
	Name: Luke Evnin Title: Member		Name: Luke Evnin Title: Member

MPM ASSET MANAGEMENT INVESTORS BV4 LLC		MPM BIOVENTURES IV STRATEGIC FUND, L.P.

By:	MPM BioVentures IV LLC its Manager	By:	MPM BioVentures IV GP LLC, its General Partner

By:	/s/ Luke Evnin	By:	MPM BioVentures IV LLC,
	Name: Luke Evnin Title: Member		its Managing Member

		By:	/s/ Luke Evnin
		Name: Title:	Luke Evnin Member

MPM BIOVENTURES IV GP LLC		MPM BIOVENTURES IV LLC

By:	MPM BioVentures IV LLC,	By:	/s/ Luke Evnin
	its Managing Member	Name: Title:	Luke Evnin Member

By:	/s/ Luke Evnin
Name: Title:	Luke Evnin Member

By:	/s/ Luke Evnin	By:	/s/ Ansbert Gadicke
	Name: Luke Evnin		Name: Ansbert Gadicke

By:	/s/ Vaughn M. Kailian	By:	/s/ James Paul Scopa
	Name: Vaughn M. Kailian		Name: James Paul Scopa

By:	/s/ Todd Foley
	Name: Todd Foley

Page 18 of 18